By March 1, more than 9000 people in the U.S. may have already been infected by COVID-19 (coronavirus), far more than the number that had been publicly reported, according to a new Cedars-Sinai study.
n open-access American Journal of Roentgenology (AJR) Collections article detailing how a tertiary hospital in Singapore responded to the outbreak of severe acute respiratory syndrome (SARS) offers a thorough summary of ground operational considerations for radiology departments presently reacting to the coronavirus disease (COVID-19) epidemic.
How individuals respond to government advice on preventing the spread of COVID-19 will be at least as important, if not more important, than government action, according to a new commentary from researchers at the University of Oxford and Imperial College London in the UK, and Utrecht University and the National Institute for Public Health and the Environment in the Netherlands.
“The new virus originating from Wuhan is the third coronavirus that has made the ‘jump’ from animals to humans,” explains Enrico Bucci, Ph.D., professor and research scientist at the Sbarro Health Research Organization (SHRO), at Temple University in Philadelphia.
Immunotherapy using LEAPS peptide technology may be able to reduce COVID-19 viral load and tissue damage resulting from infection in the lungs.
A protein produced by the human immune system can potently inhibit several coronaviruses, including the one behind the current COVID-19 outbreak.
The world is bracing for the impact of the novel coronavirus, COVID-19, which has now spread to over 30 countries, infecting more than 80,000 people with over 2,600 deaths globally.
The world is bracing for the impact of the novel coronavirus, COVID-19, which has now spread to over 30 countries, infecting more than 80,000 people with over 2,600 deaths globally.
n article by radiologists from Wuhan, China--published open-access and ahead-of-print in the American Journal of Roentgenology (AJR)--concluded that chest CT had a low rate of misdiagnosis of COVID-19 (3.9%, 2/51) and could help standardize imaging features and rules of transformation for rapid diagnosis; however, CT remains limited for the identification of specific viruses and distinguishing between viruses.
With seven reported cases in Florida to-date, FAU emergency medicine resident physicians prepared for the threat of a coronavirus contagion using a simulated or “mock” disaster scenario at FORTS Medical. The simulation involved a cruise ship dock-setting scenario and mock passengers were transported by bus. The passengers stormed into the large warehouse to challenge the resident physicians to react and respond quickly to triage the patients. About 100 people participated in the half-day simulation including local nurses, paramedics, and student and community actors.
On March 5, U.S. House and Senate lawmakers introduced the VALID Act, which would give the Food and Drug Administration (FDA) new, expansive powers to regulate laboratory developed tests—tests that are already regulated by the Centers for Medicare and Medicaid Services (CMS) and are subject to stringent personnel, quality control, and proficiency testing requirements. This bill promotes duplicative, costly federal regulations for clinical laboratories that will result in decreased patient access to essential medical tests. AACC urges Congress not to act on this bill until its impact on healthcare can be thoroughly evaluated.
A University of Washington researcher calculates that 14.4 million workers face exposure to infection once a week and 26.7 million at least once a month in the workplace, pointing to an important population needing protection as the novel coronavirus disease, COVID-19, continues to break out across the U.S.
As the coronavirus disease 2019 —or COVID-19— continues to spread, it disrupts world markets, supply chains and entire economies. As of March 5, nearly 100,000 people were confirmed infected and more than 3,000 deaths attributed to the disease.The spread of coronavirus continues to create instability on a global scale.
COVID-19 is similar in symptoms to the seasonal flu, but to recognize it there is a different procedure and we have to act accordingly
A handy checklist to help you decide whether to travel for spring break, in light of COVID-19.
Collaboration combines Harbour BioMed’s proprietary H2L2 Harbour Mice® platform for fully human monoclonal antibody generation with Mount Sinai’s translational medical research expertise.
FACULTY Q&ARavi Anupindi.Ravi Anupindi is a professor of technology and operations and faculty director for the Center for Value Chain Innovation at the University of Michigan’s Ross School of Business. He discusses how companies can deal with the COVID-19 outbreak.Ravi Anupindi.What can companies do right now to deal with supply chain interruptions?Anupindi: It is important to recognize that virus outbreaks are different from other types of disruptions like fires, floods and earthquakes.
Knowing that hygiene, cleaning and disinfecting products are important tools in preventing the spread of infections, the American Cleaning Institute (ACI) website now features a “Cleaning for Coronavirus” page with updated information for consumers and companies alike.
Faculty Q&AAs the coronavirus spreads throughout the country, an increasing number of American health care workers helping to treat patients are contracting the infection.Christopher Friese.Christopher Friese, the Elizabeth Tone Hosmer Professor of Nursing at the School of Nursing and professor of health management and policy at the School of Public Health, leads a research team focused on health care delivery in high-risk settings.
Professor shares what people can do now should the infection spread.
A coronavirus app coupled with machine intelligence will soon enable an individual to get an at-home risk assessment based on how they feel and where they've been in about a minute, and direct those deemed at risk to the nearest definitive testing facility, investigators say.
Researchers at the Department of Energy’s Oak Ridge National Laboratory have used Summit, the world’s most powerful and smartest supercomputer, to identify 77 small-molecule drug compounds that might warrant further study in the fight against the SARS-CoV-2 coronavirus, which is responsible for the COVID-19 disease outbreak.
National Comprehensive Cancer Network Postpones 2020 Annual Conference, Citing Precautions against Potential Patient Exposure to COVID-19
A study of social interactions among vampire bats that felt sick suggests family comes first when illness strikes – and may help explain which social interactions are most likely to contribute to disease transmission.
The American Association of Nurse Anesthetists (AANA) has compiled resources to help Certified Registered Nurse Anesthetists (CRNAs) develop strategic steps for managing patients with expected or confirmed infection of the Coronavirus Disease 2019 (COVID-19).
A Baylor University interior design team is assisting Decon7 Systems — manufacturer of a powerful disinfectant used by the military, first responders and, most recently, hospitals in China as they battle Coronavirus Disease (COVID-19) 19 — in designing a hyperclean play space for children with diseases that compromise their immunity.
A multi-center study (n=101) of the relationship between chest CT findings and the clinical conditions of coronavirus disease (COVID-19) pneumonia--published ahead-of-print and open-access in the American Journal of Roentgenology (AJR)--determined that most patients with COVID-19 pneumonia have ground-glass opacities (GGO) (86.1%) or mixed GGO and consolidation (64.4%) and vascular enlargement in the lesion (71.3%).
Little data is available about the ability of antiviral drugs used to treat COVID-19, coronavirus, to enter breastmilk, let alone the potential adverse effects on breastfeeding infants.
With the help of a $1.98 million award from the NIH, Wayne State University researchers are working to develop biomarker technology for identification of biomarkers of sarcoidosis, an inflammatory disease of unknown causes that affects multiple organs in the body.
Integrating travel history information into routine medical assessments could help stem the rapidly widening COVID-19 epidemic, as well as future pandemics, infectious disease specialists recommend in the Annals of Internal Medicine.
.ROCKVILLE, MD – As concern continues to grow concerning the novel coronavirus, COVID-19, so does the opportunity for misinformation to spread as the public searches for reliable information on infection and means of protection.
One-third of Americans do not have access to paid sick leave. Only the U.S. and Japan do not mandate a national sick leave benefit. Currently, seven states in the U.S. mandate that employers provide paid sick leave benefits. Given the latest information from the U.S. CDC regarding the potential impact that the coronavirus could have on the nation, researchers urge that it is critical to consider the role paid sick leave has in stopping the spread of a contagious virus.
While COVID-19, previously known as the novel coronavirus, was first reported in China, it was recently declared a global health emergency by the World Health Organization. Because most cases have been in China, clinicians elsewhere may be unfamiliar with how the virus appears in the lungs.
A monthly roundup of research briefs showcasing recent scientific advances led by Beth Israel Deaconess Medical Center faculty.
A potential drug target has been identified in a newly mapped protein of SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19). The structure was solved by a team including the University of Chicago (U of C), the U.S. Department of Energy’s (DOE) Argonne National Laboratory, Northwestern University Feinberg School of Medicine and the University of California, Riverside School of Medicine (UCR).
Polling locations across the country employ different methods of casting ballots, like using pens, felt-tip markers or touch screens — all hotbeds for germs.
Dean Headley, co-author of the national Airline Quality Rating from Wichita State University, says public concerns over COVID-19 will mostly negatively affect air travel internationally, but will certainly have some impact on domestic air travel as the virus spreads.
A group of University of Alberta researchers who have discovered why the drug remdesivir is effective in treating the coronaviruses that cause Middle East respiratory syndrome (MERS) and severe acute respiratory syndrome (SARS) expect it might also be effective for treating patients infected with the new COVID-19 strain.
An international team of clinicians and researchers for the first time have described the pathology of the SARS-CoV-2, or coronavirus, and published their findings in the Journal of Thoracic Oncology, the journal of the International Association for the Study of Lung Cancer.
Emergency physician-led teams are on the frontlines of coronavirus treatment, prevention and response.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right